• About us
  • Core Technology
  • Bio-Service
  • Investors
  • Careers
中文 English
  • About us
    • Introduction
    • Information
      • Announcement
      • Events
    • Management Team
      • Members
      • Consultants
    • Contact us
  • Core Technology
    • New medicine development platform
      • Skin diseases
      • metabolic diseases
      • Anti-inflammation
      • Diseases related to deficient mitochondrion
      • Others
  • Bio-Service
    • Scientific products
      • Western blot reagent
      • Antibody production reagent
      • Reagent for protein purification
      • Proteome experiment reagent
      • Buffer Solution
    • Supplier
      • Lumiprobe
      • Rigaku Reagents
    • Service
      • Quantitative MS and systematic biological analysis experiment service
      • Protein identity certification experiment service
      • Microarray and biological information analysis experiment service
  • Investors
    • Public information
    • Downloading
      • Prospectus
      • Annual Reports of Shareholders
      • Financial Statement
  • Careers
  • Public information
  • Downloading
  • Prospectus
  • Annual Reports of Shareholders
  • Financial Statement

Investors

    • >
  • Investors
    • > Financial Statement
  • Public information
  • Downloading
    • Prospectus
    • Annual Reports of Shareholders
    • Financial Statement

Financial Statement

    暫無資料
  • +886-2-26270835
  • +886-2-26270836
  • 6F.-3, No.21, Ln.583, Ruiguang Rd., Neihu Dist., Taipei 11492, Taiwan (R.O.C.)
Copyright © 2017 ENERGENESIS BIOMEDICAL CO., LTD. All Rights Reserved. Design by choice